Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
227.79
+2.45 (1.09%)
At close: Apr 28, 2026, 4:00 PM EDT
227.23
-0.56 (-0.25%)
After-hours: Apr 28, 2026, 4:42 PM EDT

Company Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics.

This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand.

The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson
Johnson & Johnson logo
Country United States
Founded 1886
IPO Date Sep 24, 1944
Industry Drug Manufacturers - General
Sector Healthcare
Employees 138,200
CEO Joaquin Duato

Contact Details

Address:
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States
Phone 732 524 0400
Website jnj.com

Stock Details

Ticker Symbol JNJ
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000200406
CUSIP Number 478160104
ISIN Number US4781601046
Employer ID 22-1024240
SIC Code 2834

Key Executives

Name Position
Joaquin Duato Chief Executive Officer and Chairman
Joseph James Wolk CPA Executive Vice President and Chief Financial Officer
Jennifer L. Taubert Executive Vice President and Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D. Executive Vice President of Innovative Medicine and Research & Development
Timothy Schmid Executive Vice President and Worldwide Chairman of MedTech
Robert J. Decker Jr. Controller and Chief Accounting Officer
James Swanson Executive Vice President and Chief Information Officer
Darren Snellgrove Vice President of Investor Relations
Dirk Brinckman Chief Compliance Officer
Elizabeth Forminard J.D. Executive Vice President and Chief Legal Officer

Latest SEC Filings

Date Type Title
Apr 28, 2026 8-K Current Report
Apr 22, 2026 10-Q Quarterly Report
Apr 14, 2026 8-K Current Report
Mar 26, 2026 SCHEDULE 13G/A Filing
Mar 18, 2026 13F-HR/A Filing
Mar 18, 2026 13F-HR/A Filing
Mar 11, 2026 ARS Filing
Mar 11, 2026 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 11, 2026 DEF 14A Other definitive proxy statements
Feb 27, 2026 144 Filing